You can dress it up anyway you want it's still the only big pharma partnership the company has and it's there 6th at that the first 5 walked and were all looking good up until the point they left. Well certainly 3 of them were the other 2 not so sure. Anyway "impecable timing" is still a 50/50 call right on the edge of Genentech making either a make or break decision.
If Genentech says yes who knows i guess it depends on the terms and if either hype or validation punch it finally getting someone to ho outside the lab - sure i'd love to see 10c but with current shares on issue that values it over $200m and a long way above the potential total value in 5-10 years time if Genentech sees a drug right through to market.
Fingers crossed but certainly no expectation & will be watching October closely - it worked well with Janssen trusting days to lighten positions.
PYC Price at posting:
1.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)